A detailed history of Private Capital Group, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Private Capital Group, LLC holds 3,423 shares of ABBV stock, worth $610,628. This represents 0.39% of its overall portfolio holdings.

Number of Shares
3,423
Previous 3,551 3.6%
Holding current value
$610,628
Previous $576,000 9.03%
% of portfolio
0.39%
Previous 0.13%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 28, 2022

SELL
$137.62 - $174.96 $17,615 - $22,394
-128 Reduced 3.6%
3,423 $524,000
Q1 2022

Apr 21, 2022

BUY
$131.98 - $163.75 $24,152 - $29,966
183 Added 5.43%
3,551 $576,000
Q4 2021

Jan 24, 2022

SELL
$107.43 - $135.93 $13,106 - $16,583
-122 Reduced 3.5%
3,368 $456,000
Q3 2021

Oct 13, 2021

SELL
$106.4 - $120.78 $851 - $966
-8 Reduced 0.23%
3,490 $377,000
Q2 2021

Jul 26, 2021

SELL
$105.21 - $117.21 $7,469 - $8,321
-71 Reduced 1.99%
3,498 $394,000
Q1 2021

Apr 12, 2021

SELL
$102.3 - $112.62 $277,949 - $305,988
-2,717 Reduced 43.22%
3,569 $386,000
Q4 2020

Jan 26, 2021

SELL
$80.49 - $108.67 $53,445 - $72,156
-664 Reduced 9.55%
6,286 $674,000
Q3 2020

Nov 12, 2020

BUY
$85.91 - $100.83 $52,147 - $61,203
607 Added 9.57%
6,950 $609,000
Q2 2020

Aug 13, 2020

BUY
$73.37 - $98.18 $25,386 - $33,970
346 Added 5.77%
6,343 $623,000
Q1 2020

May 07, 2020

BUY
$64.5 - $97.79 $103,522 - $156,952
1,605 Added 36.54%
5,997 $457,000
Q4 2019

Feb 14, 2020

SELL
$72.13 - $90.25 $184,652 - $231,040
-2,560 Reduced 36.82%
4,392 $388,000
Q3 2019

Nov 13, 2019

BUY
$62.98 - $75.72 $25,506 - $30,666
405 Added 6.19%
6,952 $526,000
Q2 2019

Aug 15, 2019

SELL
$65.7 - $83.98 $26,542 - $33,927
-404 Reduced 5.81%
6,547 $607,000
Q1 2019

Apr 26, 2019

BUY
$77.14 - $90.79 $34,790 - $40,946
451 Added 6.94%
6,951 $560,000
Q4 2018

Jan 28, 2019

SELL
$77.85 - $96.01 $58,387 - $72,007
-750 Reduced 10.34%
6,500 $599,000
Q3 2018

Oct 31, 2018

SELL
$88.91 - $98.84 $82,063 - $91,229
-923 Reduced 11.29%
7,250 $685,000
Q2 2018

Aug 09, 2018

BUY
$89.78 - $106.23 $10,594 - $12,535
118 Added 1.46%
8,173 $757,000
Q1 2018

May 16, 2018

BUY
$92.01 - $123.21 $661,183 - $885,387
7,186 Added 826.93%
8,055 $762,000
Q4 2017

May 18, 2018

SELL
$89.56 - $98.21 $771,022 - $845,489
-8,609 Reduced 90.83%
869 $760,000
Q4 2017

Mar 07, 2018

BUY
$89.56 - $98.21 $848,849 - $930,834
9,478
9,478 $1.14 Million

Others Institutions Holding ABBV

About AbbVie Inc.


  • Ticker ABBV
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 1,768,099,968
  • Market Cap $315B
  • Description
  • AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...
More about ABBV
Track This Portfolio

Track Private Capital Group, LLC Portfolio

Follow Private Capital Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Private Capital Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Private Capital Group, LLC with notifications on news.